Replies to post #879 on Ariad Pharmaceuticals Inc fka ARIA

[rkrw]

The trial isn't for all types of sarcoma.

I wouldn't call you a basher. I don't care.

[Whosetosay]

Your observations and opinions appear quite reasonable to me. As presented in your post this go around, they don't strike me as bashing, but more like a skeptical long.

Overall, I am a bit more optimistic, though I am further increasing my risk by investing more than my optimism would normally warrant.